Mindprint implements market-leading automation solution for Ockham Oncology

Mindprint Inc. and Ockham Development, Inc. have implemented an innovative automation software system to help the global CRO manage trials efficiently to ensure a more focused approach to its core oncology mission.

Hits: 6796

Read more ...

Astellas and Ambrx initiate collaboration for discovery and development of antibody drug conjugates for oncology

AstellasAstellas Pharma Inc. (Tokyo: 4503, "Astellas") entered into a collaboration with Ambrx Inc. ("Ambrx") for the discovery and development of novel antibody drug conjugates ("ADCs"). ADCs allow for the targeted delivery of drugs to the target tissue. Ambrx creates optimized ADCs using its site-specific conjugation technology along with proprietary linkers and payloads.

Hits: 6133

Read more ...

Luqa Pharmaceuticals and Stratpharma enter into an exclusive agreement

Luqa Pharmaceuticals announced today that it has entered into an exclusive agreement with Stratpharma AG of Switzerland to promote, sell, and distribute Strataderm®, in the People's Republic of China.

Hits: 5793

Read more ...

Sanofi and Astellas to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc.

Astellas Pharma Inc.Sanofi and Astellas Pharma Inc. announced that the two companies agreed to dissolve sanofi-aventis Yamanouchi Pharmaceutical Inc., a joint company of Sanofi and Astellas.

Hits: 9109

Read more ...

Forest Laboratories Completes Acquisition of Clinical Data, Inc.

Forest LaboratoriesForest Laboratories, Inc. (NYSE: FRX) ("Forest") has successfully completed its acquisition of Clinical Data, Inc. (NASDAQ: CLDA) ("Clinical Data") by means of what is known as a short-form merger under Delaware law.

Hits: 7286

Read more ...

Forest Laboratories, Inc. Finalizes Previously Disclosed Settlement of U.S. Government Investigations

Forest Laboratories, Inc.Forest Laboratories, Inc. (NYSE: FRX) has finalized a previously reported agreement-in-principle to resolve all aspects of the investigations led by the United States Department of Justice (DOJ) and the United States Attorney's Office for the District of Massachusetts that began in January 2004 relating to past marketing, sales, and other activities in connection with Celexa(R), Lexapro(R), and a formulation of Levothroid(R) that Forest ceased distributing in 2003.

Hits: 5446

Read more ...

Covex S.A. creates 2000 jobs with the onset of a new agroindustrial project in Latin America

Covex S.A.Covex S.A., leader in the manufacture of products aimed at improving cerebral functions, successfully reaches the first stage of its introduction in Latin America, as it begins to harvest medicinal plants on an industrial scale, for the onset of its new agroindustrial expansion.

Hits: 5108

Read more ...

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]